Peer Review History
| Original SubmissionMay 13, 2020 |
|---|
|
PONE-D-20-14030 Developing a national birth cohort for child health research using a hospital admissions database in England: the impact of changes to data collection practices PLOS ONE Dear Dr. Zylbersztejn, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Major objections have been raised during the review process about the methods and attainable aims of the described process and database: Although some of them may be out of reach given the setting of the study, we invite you to consider submitting a revised version of the manuscript that addresses the remarks made by the reviewers. Would you choose to do so, please address all the points made by the reviwers in the below report. Please submit your revised manuscript by Sep 04 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Umberto Simeoni Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a manuscript describing hospital episode statistics (HES) data on births in the UK and assessing whether this data can be used for following up children using routine data. While this paper provides interesting descriptive information about England’s HES statistics, the research question (s) are difficult to discern. It reads, at times, more like a report describing the constitution of a dataset, than a scientific study. The authors need to be more straightforward about the central premise of their study, clarify the research aims and place the results in a broader international context. The introduction and title of the MS place emphasis on the methods for identifying a “national birth cohort” – the authors begin by citing the failure of the 2015 effort to establish the Lifestudy and then refer to examples from other countries where register data are used for research. From the onset, the authors need to clarify what they mean by “national birth cohort”. There is a large difference between being able to link hospital data and studying some longer-term (mainly hospital-related) outcomes and creating a national birth cohort (as initiated in many countries, see https://lifecycle-project.eu/). When the authors claim in their discussion that they have shown the feasibility of using HES to create a national birth cohort, this is not convincing if they mean this cohort to be an alternative for cohort studies such as Lifestudy or if comparing with the Nordic registers. Many other issues remain outstanding such as whether data can be linked to other sources, issues of consent, etc… The research questions underlying the study aims are not clear. It is stated: “In this study, we present methods for developing a national birth cohort using HES and provide Stata code for cohort derivation. We demonstrate how long-term health outcomes of children in the cohort (such as hospital admission or death) are affected by changes in the quality of recorded identifiers used for linkage of birth admissions to consecutive hospital admissions within HES and to other datasets. We suggest how linkage error can be addressed retrospectively to create hospital record trajectories for children and adolescents from 1997 onwards with accurate linkage to their birth episodes. Concerning the first aim, presenting methods and giving code is transparent and helpful for other researchers, but does not constitute a research question. So, although instructions to identify births are provided, there is no test to show how this definition improves on others. There is no discussion about whether these methods are similar to those used in other datasets (for instance: Kuklina EV, Whiteman MK, Hillis SD, et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J. Jul 2008;12(4):469-477). Most studies using hospital discharge data use algorithms to identify births. Second, the section on how changes to the quality of recorded identifiers improved linkage and quality of indicators relying on linkage isn’t particularly surprising and therefore, while it is reassuring to find that better linkage seems to improve the accuracy of some indicators (leading to higher admission rates, for instance), it’s not clear how this adds to overall knowledge about how hospital episode statistics can be used for research on children. Furthermore, there is no gold standard - in the case of hospital admissions – and there may still be substantial errors. In terms of the conceptualisation of the study, the database constituted by the authors only allows a partial evaluation of the capabilities of the HES data as mothers are not linked with their babies, even though the authors state that this is possible and would improve the quality of data. The authors need to justify why they developed this study without linking these data. Given the large amounts of missing data, it is not clear why the authors did not describe the characteristics of births with and without missing data – is this related to the hospital? The region? The reader also wonders whether there has there been any validation of these data with medical records to assess the validity of the data? Many countries use hospital discharge data for research; putting the HES within this broader international context would be useful. How do these results compare to those in other countries? Abstract –“Numbers for Babies (NN4B) system for allocation of unique National Health Service (NHS) number at birth in Q4 2002” is not interpretable as a stand alone sentence. While multiples pose many problems for linkages and use of administrative and register data, the solution of eliminating them is not optimal. Reviewer #2: This study described methods used to create a national birth cohort using HES and aimed to evaluate the quality of linkage between births and follow-up records and its impact on two health outcomes in children. Overall, I think this is a well written and informative study. To help further improve the manuscript it would be good if the authors could address the following points: - It’s great to see that the authors have provided a link to the Stata code for derivation of the cohort. Can they just check that this is complete and consistent with all the steps they describe in the paper e.g. from a quick scan of the Stata code I could not see any code for excluding non-English residents. Similar, it would be really helpful if they can make sure that all the data cleaning steps in the Stata code are described in the appendix of the paper e.g. from the Stata code it looks like they have a number of additional cleaning steps such as those described under the overall heading ‘Additional data cleaning & duplication to ensure one birth episode per HESID’ that are currently not described in the appendix of the paper. - Discussion, key findings & abstract – when the authors say the proportion of babies with hospital readmission after birth increased by a third to 17.7% is this compared to the proportion with hospital readmission in Q1 1998? If so, can the authors make this explicit in both the discussion and abstract or consider instead stating what I think is probably the more informative figure of 6.1% compared to the expected value based on the trend before Q4 2002. - Page 4 of the discussion - From the data the authors have it cannot be stated with certainty that babies with longer birth admission were more likely to have their NHS number updated during the hospital stay. Also are the 35% and 25% figures quoted on page 4 of the discussion compared to the hospital readmission proportions in Q1 1998? If so, can the authors make this explicit. However, I again would consider the 5.9% and 8.6% figures (compared to expected value based on trend before Q4 2002) that the authors quote in the results to be the most relevant – and these figures actually imply a greater shift in the readmission rate occurred for births with longer not shorter birth admissions. Other minor points: - Abstract discussion – even if births prior to 2003 are not correctly re-linked, HES has the potential to provide national longitudinal hospitalisation birth cohort data for child research so suggest slightly reword last sentence to something like “HES has the potential to provide national longitudinal hospitalisation birth cohort data for child health research, but births prior to 2003 need correctly re-linking to follow-up records.” - Reference 6 relates to a data linkage study conducted in Scotland so would not cite it with reference to Canada as have done in the introduction. - Introduction – please make it explicit that HES includes all births in English NHS hospitals and presumably does the 97.4% figure relate to the proportion of all births in England rather than England and Wales? - Methods - suggest rephrasing first sentence under study participants to something like “We developed a cohort of singleton live births between 1st January 1998 and 31st December 2015 to mother’s resident in England based on birth…” - Methods – you state that you cleaned data on maternal age but this is not detailed in appendix 2. - Can you make it a bit more explicit in the methods that you did not use information recorded in the mother’s delivery records in this study. - It would helpful for completeness to include the details of the HES field/variable names you used to identify the risk factors in the appendix. - In the methods section you state that you defined hospital admissions as a continuous period of time that a child spent under hospital care and that hospital transfers and admissions within 1 day of each other were treated as one inpatient admission which seems to contradict with what you say in appendix 3 (hospital admission defined as total time spent by a patient in one hospital, with hospital transfers classified as separate inpatient admissions) – please clarify. - In the outcomes section of the methods where you define infant deaths suggest rephrasing slightly for clarity to: ‘Infant deaths were defined where a linked death record was found (that is, via link to ONS mortality record) or the discharge method in the hospital record was recorded as ‘died’. - Methods – the first time you mention the implementation of NHS numbers for babies, did you mean “Q4 2002..” rather than “Q3/Q4 2002..”? - Can you clarify that you were looking at hospital readmission in the first year of life in the methods outcomes section and appendix table 6. - Figure 3 – would be helpful to mark the time points when the collection of identifiers used to generate HESID changed as you did for Figure 2. - Page 2 of discussion – think you need to add an ‘of’ after ‘Further work is needed to evacuate the quality” - On page 4 of the discussion would suggest softening the wording slight to something like “Fixing the postcode extraction error in 2013 did not appear to impact on quality of linkage, but…” Also, according to your Figure 1, fixing the postcode extraction error did not ensure that IMD was available for all births – it only correlated with an increase in the completeness of this variable to 89% in years 2014-2015 – can you amend the wording on page 4 of the discussion to reflect this. - It would probably be clearer to use different colours rather than different shades of grey in the figures. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Developing a national birth cohort for child health research using a hospital admissions database in England: the impact of changes to data collection practices PONE-D-20-14030R1 Dear Dr. Zylbersztejn, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Umberto Simeoni Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have been very responsive to the first round of review comments and the objectives and methods of the MS are now clearly stated. This will be a useful contribution to the literature. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-14030R1 Developing a national birth cohort for child health research using a hospital admissions database in England: the impact of changes to data collection practices Dear Dr. Zylbersztejn: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Umberto Simeoni Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .